Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|PF-06263507||PF06263507|PF 06263507||PF-06263507 is an antibody conjugate comprising an antibody that targets 5T4 conjugated to the microtubule agent, monomethylauristatin F, which may result in cell death and inhibition of tumor growth (PMID: 23223830, PMID: 28070718).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Unknown unknown||Advanced Solid Tumor||not applicable||PF-06263507||Phase I||Actionable||In a Phase I trial, treatment with PF-06263507 resulted in no objective responses, but led to stable disease in two patients with advanced solid tumors (PMID: 28070718).||28070718|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status||Covered Countries||Other Countries|